bioasis Technologies Inc. (BTI) Company Profile

bioasis Technologies Inc. Company Snapshot

bioasis Technologies Inc. operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares bioasis Technologies Inc. with three other miscellaneous service companies in North America: GeneNews Limited (2017 sales of 533,131.94 Canadian Dollars [US$415,533.70 ] ), Eyegate Pharmaceuticals Inc of the United States ($407,518.00 ), and Sesen Bio Inc which is also based in the United States ($425,000.00 of which 100% was Protein Therapeutic).

Sales Analysis.

bioasis Technologies Inc.

Stock Data:

Recent Stock Performance:

Current Price (5/25/2018): .65
(Figures in Canadian Dollars)

1 Week	0.0%	13 Weeks	1.6%

4 Weeks	1.6%	52 Weeks	-15.6%

bioasis Technologies Inc. Key Data:

Ticker:	BTI	Country:	Canada

Exchanges:	TOR	Major Industry:	Commercial Services & Supplies

		Sub Industry:	Commercial Physical Research

2017 Sales	512,966 (Year Ending Jan 2018).	Employees:	N/A

Currency:	Canadian Dollars	Market Cap:	33,632,269

Fiscal Yr Ends:	February	Shares Outstanding:	51,741,952

Share Type:		Closely Held Shares:	5,519,900

Feedback | Terms and Conditions | Privacy Policy | Site Index

CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.